About Rob Michiels
Rob Michiels is a 30-year U.S. veteran of the medical device industry. He most recently served as chief operating officer (COO) of CoreValve; and President and COO of InterVentional Technologies. Rob Michiels is a director of CardiAQ Valve Technologies, a privately held company based in Winchester, Massachusets. Rob Michiels is a founding partner of CONSILIUM, a medical device market research company active in identifying, funding and greenhousing start-up technologies. Fluent in English, French and Dutch languages, he holds a bachelor's degree in economics from Antwerp University in Belgium and a Masters in business administration (MBA) from Indiana University.
Rob Michiels Headquarter Location
Latest Rob Michiels News
Sep 19, 2016
News » 2016 » 09 » 16 » FEops elects Rob Michiels as Chairman FEops elects Rob Michiels as Chairman Former CardiAQ Valve Technologies CEO and CoreValve COO says FEops' "predictive procedure-planning platform" may be crucial to the ultimate-outcome success of transcatheter-based valve therapies "Certainly, Rob Michiels is one of the most experienced, most successful executives in the cardiovascular industry. " Matthieu De Beule, PhD, CEO, FEops Ghent, Belgium: 16 September 2016 - FEops, which is developing "future-generation planning technology for transcatheter valve therapies", today announced that it has elected Rob Michiels to serve as Chairman of the Board of Directors, effectively immediately. Until September 2015, Michiels was Chief Executive Officer at CardiAQ Valve Technologies, the Transcatheter Mitral Valve Replacement (TMVR) company, which was acquired by Edwards Lifesciences. More info on FEops ' website.